FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Filip De Keyser

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Concepts & Ideas

Phenomena

Fluorescent Antibody Technique, Indirect

Co-author Network

Publications

TOP 3
Vanessa Smith; Jens T van Praet; Saskia Decuman; Ellen Deschepper; Dirk Elewaut; Yves Piette; Filip De Keyser
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.
Vanessa Smith; Alberto Sulli; Carolien Bonroy; Filip De Keyser; Saskia Decuman; Ellen Deschepper; Yves Piettte; Maurizio Cutolo
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study.
Carolien Bonroy; Dieter Deforce; Katrien M J Devreese; Vanessa Smith; Jens Van Praet; Katleen Van Steendam; Filip De Keyser
Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Filip De Keyser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vanessa Smith; Jens T van Praet; Saskia Decuman; Ellen Deschepper; Dirk Elewaut; Yves Piette; Filip De Keyser
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.
The Journal of rheumatology 2013;40(1):52-7.
2012: Vanessa Smith; Alberto Sulli; Carolien Bonroy; Filip De Keyser; Saskia Decuman; Ellen Deschepper; Yves Piettte; Maurizio Cutolo
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study.
Annals of the rheumatic diseases 2012;71(10):1636-9.
2012: Carolien Bonroy; Dieter Deforce; Katrien M J Devreese; Vanessa Smith; Jens Van Praet; Katleen Van Steendam; Filip De Keyser
Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques.
Clinical and experimental rheumatology 2012;30(5):748-55.
2012: Séverine Vermeire; Pierre L Masson; Franck Carbonnel; Pierre G Coulie; Filip De Keyser; Vincent Geenen; Johanna M W Hazes; Edouard Louis
Management of inflammatory bowel disease in pregnancy.
Journal of Crohn's & colitis 2012;6(8):811-23.
2012: Seher Arat; Daniel Blockmans; luwis Diya; Frédéric A Houssiau; Vanessa Smith; Marie Vanthuyne; Patrick Verschueren; Koen Van den Heede; Filip De Keyser; Ellen De Langhe; René Westhovens
The association of illness perceptions with physical and mental health in systemic sclerosis patients: an exploratory study.
Musculoskeletal care 2012;10(1):18-28.
2012: Saskia Decuman; Ellen Deschepper; Vanessa Smith; Sofie Verhaeghe; Frans Vermeiren; Filip De Keyser
Work participation and work transition in patients with systemic sclerosis: a cross-sectional study.
Rheumatology (Oxford, England) 2012;51(2):297-304.
2011: Johanna M W Hazes; Edouard Louis; Pierre Masson; Séverine Vermeire; Franck Carbonnel; Pierre G Coulie; Vincent Geenen; Filip De Keyser
Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.
Rheumatology (Oxford, England) 2011;50(11):1955-68.
2011: Jens T Van Praet; Katleen Van Steendam; Carolien Bonroy; Georges de Bruyne; Dieter Deforce; Dirk Elewaut; Tsuneyo Mimori; Vanessa Smith; Filip De Keyser
Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
Rheumatology (Oxford, England) 2011;50(7):1302-9.
2011: M Devinck; Bert Vander Cruyssen; K Lambein; Filip De Keyser; M Praet; Guy G Brusselle
Microscopic polyangiitis involving the breast.
Acta clinica Belgica 2011;66(2):139-41.
2011: Jens T Van Praet; Nele Degryse; Dirk Elewaut; Marc Haspeslagh; Vanessa Smith; Filip De Keyser
Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study.
Arthritis research & therapy 2011;13(1):R35.
2011: Vanessa Smith; Filip De Keyser; Carmen Pizzorni; Jens T Van Praet; Saskia Decuman; Alberto Sulli; Ellen Deschepper; Maurizio Cutolo
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions.
Annals of the rheumatic diseases 2011;70(1):180-3.
2010: Jean-François Rahier; Michel Moutschen; Alfons Van Gompel; Marc Van Ranst; Edouard Louis; Siegfried Segaert; Pierre Masson; Filip De Keyser
Vaccinations in patients with immune-mediated inflammatory diseases.
Rheumatology (Oxford, England) 2010;49(10):1815-27.
2010: Robert B M Landewé; Jos G A Houbiers; Filip Van den Bosch; Joanna in't Hout; Patrick C P M Verschueren; Jan H Meijerink; F H J van den Hoogen; Bedrich A Masek; George A W Bruyn; Jacques M G W Wouters; Alexandre E Voskuyl; Jacob M van Laar; Johannes J W Bijlsma; Désirée M F M van der Heijde; Ferdinand C Breedveld; Leo B A van de Putte; André M M Miltenburg; Filip De Keyser
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial.
Annals of the rheumatic diseases 2010;69(9):1655-9.
2010: Vanessa Smith; Carmen Pizzorni; Filip De Keyser; Saskia Decuman; Jens T Van Praet; Ellen Deschepper; Alberto Sulli; Maurizio Cutolo
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study.
Annals of the rheumatic diseases 2010;69(6):1092-6.
2010: Lode Melis; Bernard Vandooren; Elli Kruithof; Peggy Jacques; Martine De Vos; Herman Mielants; Gust Verbruggen; Filip De Keyser; Dirk Elewaut
Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.
Annals of the rheumatic diseases 2010;69(3):618-23.
2010: Bert Vander Cruyssen; Patrick Durez; Rene Westhovens; Marie-Joelle Kaiser; Ilse Hoffman; Filip De Keyser
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies.
Arthritis research & therapy 2010;12(5):R169.
2010: Katleen Van Steendam; Kelly Tilleman; Marlies De Ceuleneer; Filip De Keyser; Dirk Elewaut; Dieter Deforce
Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins.
Arthritis research & therapy 2010;12(4):R132.
2010: Bert Vander Cruyssen; Patrick Durez; René Westhovens; Filip De Keyser
Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity.
Arthritis research & therapy 2010;12(3):R77.
2010: V Smith; J T Van Praet; Bernard Vandooren; B Van der Cruyssen; J-M Naeyaert; S Decuman; Dirk Elewaut; Filip De Keyser
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study.
Annals of the rheumatic diseases 2010;69(1):193-7.
2009: J T Van Praet; Bert Vander Cruyssen; C Bonroy; V Smith; J Delanghe; Filip De Keyser
Validation of a new screening strategy for anti-extractable nuclear antigen antibodies.
Clinical and experimental rheumatology 2009;27(6):971-6.
2009: Katrien van Beneden; Ken Coppieters; W Laroy; Filip De Keyser; I E A Hoffman; Filip Van den Bosch; Bert Vander Cruyssen; M Drennan; Peggy Jacques; Pieter Rottiers; Gust Verbruggen; R Contreras; N Callewaert; Dirk Elewaut
Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis.
Annals of the rheumatic diseases 2009;68(8):1360-5.
2009: R Wittoek; Filip De Keyser; Annelies Boonen; kurt de vlam; Nathan Vastesaeger; Herman Mielants; Bert Vander Cruyssen
Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio products.
Clinical and experimental rheumatology 2009;27(2):272-6.
2009: I E A Hoffman; B R Lauwerys; Filip De Keyser; T W J Huizinga; D Isenberg; L Cebecauer; Joke Dehoorne; Rik Joos; G Hendrickx; Frédéric A Houssiau; Dirk Elewaut
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
Annals of the rheumatic diseases 2009;68(3):412-5.
2008: V Smith; M Vanthuyne; Bert Vander Cruyssen; J Van Praet; F Vermeiren; H Smets; Frédéric A Houssiau; Filip De Keyser
Over-representation of construction-related occupations in male patients with systemic sclerosis.
Annals of the rheumatic diseases 2008;67(10):1448-50.
2008: Bert Vander Cruyssen; Leonor Nogueira; J Van Praet; Dieter Deforce; Dirk Elewaut; Guy Serre; Filip De Keyser
Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(4):542-6.
2007: Bert Vander Cruyssen; Lieve Nuytinck; Luc Boullart; Dirk Elewaut; W Waegeman; M Van Thielen; E De Meester; Katleen Lebeer; R Rossau; Filip De Keyser
Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis.
Rheumatology (Oxford, England) 2007;46(12):1792-5.
2007: Bert Vander Cruyssen; André M M Miltenburg; Filip Van den Bosch; Jos G A Houbiers; Ruth Wittoek; Mieke Boots; Filip De Keyser
Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activity.
The Journal of rheumatology 2007;34(10):1992-6.
2007: V Smith; Michel De Pauw; Guy G Brusselle; J Van Praet; Filip De Keyser
Re: Pulmonary arterial hypertension in connective tissue diseases.
Rheumatology (Oxford, England) 2007;46(9):1510; author reply 1510.
2007: M J C van Lierop; L den Hoed; Jos G A Houbiers; J Vencovsky; S Ruzickova; O Krystufkova; M van Schaardenburg; F van den Hoogen; Bernard Vandooren; Dominique Baeten; Filip De Keyser; Grete Sønderstrup; Ebo S Bos; Mieke Boots
Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.
Arthritis and rheumatism 2007;56(7):2150-9.
2007: Filip De Keyser
Spondyloarthropathies.
Current opinion in rheumatology 2007;19(4):333-4.
2007: Harald Peeters; S Bogaert; Debby Laukens; Pieter Rottiers; Filip De Keyser; Arlette Darfeuille-Michaud; A-L Glasser; Dirk Elewaut; Martine De Vos
CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
International journal of immunogenetics 2007;34(3):181-91.
2007: Bert Vander Cruyssen; I E A Hoffman; Isabelle Peene; Ann union; Herman Mielants; Lydie Meheus; Filip De Keyser
Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope.
Annals of the rheumatic diseases 2007;66(3):364-9.
2007: Kelly Tilleman; Ann union; Tineke Cantaert; Saskia De Keyser; Annick Daniels; Dirk Elewaut; Filip De Keyser; Dieter Deforce
In pursuit of B-cell synovial autoantigens in rheumatoid arthritis: Confirmation of citrullinated fibrinogen, detection of vimentin, and introducing carbonic anhydrase as a possible new synovial autoantigen.
Proteomics. Clinical applications 2007;1(1):32-46.
2007: Bert Vander Cruyssen; Filip De Keyser; Elli Kruithof; Herman Mielants; Filip Van den Bosch
Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo.
Annals of the rheumatic diseases 2007;66(1):138-40.
2007: Frank P Luyten; Piet Geusens; Michel Malaise; L De Clerck; René Westhovens; Frank Raeman; D Vander Mijnsbrugge; L Mathy; Jean-Philippe Hauzeur; Filip De Keyser; Filip Van den Bosch
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.
Annals of the rheumatic diseases 2007;66(1):99-106.
2006: Debby Laukens; Harald Peeters; Bert Vander Cruyssen; Tom Boonefaes; Dirk Elewaut; Filip De Keyser; Herman Mielants; Claude Cuvelier; Eric M Veys; K Knecht; P Van Hummelen; Erik Remaut; Lothar Steidler; Martine De Vos; Pieter Rottiers
Altered gut transcriptome in spondyloarthropathy.
Annals of the rheumatic diseases 2006;65(10):1293-300.
2006: Dominique Baeten; Jos G A Houbiers; Elli Kruithof; Bernard Vandooren; Filip Van den Bosch; Mieke Boots; Eric M Veys; André M M Miltenburg; Filip De Keyser
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis.
Annals of the rheumatic diseases 2006;65(8):990-7.
2006: Elli Kruithof; Leen De Rycke; Bernard Vandooren; Filip De Keyser; Oliver FitzGerald; Iain McInnes; Paul P Tak; Barry Bresnihan; Eric M Veys; Dominique Baeten
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis.
Arthritis and rheumatism 2006;54(6):1795-804.
2006: Filip De Keyser; Filip Van den Bosch; Herman Mielants
Anti-TNF-alpha therapy in ankylosing spondylitis.
Cytokine 2006;33(5):294-8.
2006: pieter dewint; I E A Hoffman; S Rogge; Rik Joos; Ann union; Joke Dehoorne; J Delanghe; Eric M Veys; Filip De Keyser; Dirk Elewaut
Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
Rheumatology (Oxford, England) 2006;45(2):204-8.
2006: Bert Vander Cruyssen; Patrick Durez; René Westhovens; Nathan Vastesaeger; Anja Geldhof; Filip De Keyser
Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'.
Arthritis research & therapy 2006;8(6):406.
2006: Bert Vander Cruyssen; Stijn Van Looy; Bart Wyns; René Westhovens; Patrick Durez; Filip Van den Bosch; Herman Mielants; Luc De Clerck; Ann Peretz; Michel Malaise; Leon Verbruggen; Nathan Vastesaeger; Anja Geldhof; Luc Boullart; Filip De Keyser
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity.
Arthritis research & therapy 2006;8(4):R112.
2006: Bert Vander Cruyssen; Tineke Cantaert; Leonor Nogueira; Cyril Clavel; Leen De Rycke; Amélie Dendoven; Mireille Sebag; Dieter Deforce; Christian Vincent; Dirk Elewaut; Guy Serre; Filip De Keyser
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.
Arthritis research & therapy 2006;8(4):R122.
2006: Fotini B Karassa; Antonella Afeltra; Ales Ambrozic; Deh-Ming Chang; Filip De Keyser; Andrea Doria; Mauro Galeazzi; Shunsei Hirohata; I E A Hoffman; Murat Inanc; Loreto Massardo; Alessandro Mathieu; Chi Chiu Mok; Gabriella Morozzi; Giovanni Sanna; Alberto J Spindler; Athanasios G Tzioufas; Taku Yoshio; John Ioannidis
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis.
Arthritis and rheumatism 2006;54(1):312-24.
2005: Elli Kruithof; Leen De Rycke; Johannes Roth; Herman Mielants; Filip Van den Bosch; Filip De Keyser; Eric M Veys; Dominique Baeten
Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
Arthritis and rheumatism 2005;52(12):3898-909.
2005: Markus Rihl; Elli Kruithof; C Barthel; Filip De Keyser; Eric M Veys; Henning Zeidler; D T Y Yu; Jens G Kuipers; Dominique Baeten
Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment.
Annals of the rheumatic diseases 2005;64(11):1542-9.
2005: Bert Vander Cruyssen; Isabelle Peene; Tineke Cantaert; I E A Hoffman; Leen De Rycke; Eric M Veys; Filip De Keyser
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.
Autoimmunity reviews 2005;4(7):468-74.
2005: Tineke Cantaert; P Coucke; Leen De Rycke; Eric M Veys; Filip De Keyser; Dominique Baeten
Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.
Annals of the rheumatic diseases 2005;64(9):1316-20.
2005: Leen De Rycke; Anthony P Nicholas; Tineke Cantaert; Elli Kruithof; Joshua D Echols; Bart Vandekerckhove; Eric M Veys; Filip De Keyser; Dominique Baeten
Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity.
Arthritis and rheumatism 2005;52(8):2323-30.
2005: P Carron; I E A Hoffman; Leen De Rycke; Isabelle Peene; Eric M Veys; Filip De Keyser; Wouter Bauters; Marleen Praet
Case number 34: Relapse of polyarteritis nodosa presenting as isolated and localised lower limb periostitis.
Annals of the rheumatic diseases 2005;64(8):1118-9.
2005: Bert Vander Cruyssen; I E A Hoffman; Hans Zmierczak; M Van Den Berghe; Elli Kruithof; Leen De Rycke; Herman Mielants; Eric M Veys; Dominique Baeten; Filip De Keyser
Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis.
Annals of the rheumatic diseases 2005;64(8):1145-9.
2005: Leen De Rycke; Bernard Vandooren; Elli Kruithof; Filip De Keyser; Eric M Veys; Dominique Baeten
Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
Arthritis and rheumatism 2005;52(7):2146-58.
2005: Leen De Rycke; Dominique Baeten; Elli Kruithof; Filip Van den Bosch; Eric M Veys; Filip De Keyser
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
Arthritis and rheumatism 2005;52(7):2192-201.
2005: Herman Mielants; Filip De Keyser; Dominique Baeten; Filip Van den Bosch
Gut inflammation in the spondyloarthropathies.
Current rheumatology reports 2005;7(3):188-94.
2005: Debby Laukens; Harald Peeters; D Marichal; Bert Vander Cruyssen; Herman Mielants; Dirk Elewaut; Pieter Demetter; Claude Cuvelier; M Van Den Berghe; Pieter Rottiers; Eric M Veys; Erik Remaut; Lothar Steidler; Filip De Keyser; Martine De Vos
CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.
Annals of the rheumatic diseases 2005;64(6):930-5.
2005: Kelly Tilleman; Katrien van Beneden; Aline Dhondt; Ilse Hoffman; Filip De Keyser; Eric M Veys; Dirk Elewaut; Dieter Deforce
Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry.
Proteomics 2005;5(8):2247-57.
2005: Leen De Rycke; Dominique Baeten; Dirk Foell; Elli Kruithof; Eric M Veys; Johannes Roth; Filip De Keyser
Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis.
The Journal of pathology 2005;206(1):17-27.
2005: Bert Vander Cruyssen; Harald Peeters; I E A Hoffman; Debby Laukens; P Coucke; D Marichal; Claude Cuvelier; Erik Remaut; Eric M Veys; Herman Mielants; Martine De Vos; Filip De Keyser
CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
Clinical and experimental immunology 2005;140(2):354-9.
2005: Sabine Chapuy-Regaud; Mireille Sebbag; Dominique Baeten; Cyril Clavel; Céline Foulquier; Filip De Keyser; Guy Serre
Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(8):5057-64.
2005: Elli Kruithof; Dominique Baeten; Filip Van den Bosch; Herman Mielants; Eric M Veys; Filip De Keyser
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy.
Annals of the rheumatic diseases 2005;64(4):529-36.
2005: I E A Hoffman; Isabelle Peene; L Cebecauer; D Isenberg; Tom W J Huizinga; Ann union; Lydie Meheus; Katrien De Bosschere; Frank Hulstaert; Eric M Veys; Filip De Keyser
Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus.
Annals of the rheumatic diseases 2005;64(2):330-2.
2005: Leen De Rycke; X Verhelst; Elli Kruithof; Filip Van den Bosch; I E A Hoffman; Eric M Veys; Filip De Keyser
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(2):299-302.
2005: Pieter Demetter; Martine De Vos; Jacques Van Huysse; Dominique Baeten; L Ferdinande; Harald Peeters; Herman Mielants; Eric M Veys; Filip De Keyser; Claude Cuvelier
Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
Annals of the rheumatic diseases 2005;64(2):321-4.
2005: Leen De Rycke; Dominique Baeten; Elli Kruithof; Filip Van den Bosch; Eric M Veys; Filip De Keyser
The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications.
Lupus 2005;14(12):931-7.
2005: Bert Vander Cruyssen; Stijn Van Looy; Bart Wyns; René Westhovens; Patrick Durez; Filip Van den Bosch; Eric M Veys; Herman Mielants; Luc De Clerck; Anne Peretz; Michel Malaise; Leon Verbruggen; Nathan Vastesaeger; Anja Geldhof; Luc Boullart; Filip De Keyser
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment.
Arthritis research & therapy 2005;7(5):R1063-71.
2005: Elli Kruithof; Dominique Baeten; Leen De Rycke; Bernard Vandooren; Dirk Foell; Johannes Roth; Juan D Cañete; Mieke Boots; Eric M Veys; Filip De Keyser
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis.
Arthritis research & therapy 2005;7(3):R569-80.
2005: Dominique Baeten; Elli Kruithof; Leen De Rycke; Mieke Boots; Herman Mielants; Eric M Veys; Filip De Keyser
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
Arthritis research & therapy 2005;7(2):R359-69.
2005: I E A Hoffman; Isabelle Peene; Hans Pottel; Ann union; Frank Hulstaert; Lydie Meheus; Katleen Lebeer; Luc De Clercq; Lieve Schatteman; Stefaan Poriau; Herman Mielants; Eric M Veys; Filip De Keyser
Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis.
Clinical chemistry 2005;51(1):261-3.
2004: Leen De Rycke; Isabelle Peene; I E A Hoffman; Elli Kruithof; Ann union; Lydie Meheus; Katleen Lebeer; Bart Wyns; Christian Vincent; Herman Mielants; Luc Boullart; Guy Serre; Eric M Veys; Filip De Keyser
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations.
Annals of the rheumatic diseases 2004;63(12):1587-93.
2004: Chunhua Yang; Jieruo Gu; Markus Rihl; Dominique Baeten; Feng Huang; Miansong Zhao; Hanwei Zhang; Walter P Maksymowych; Filip De Keyser; Eric M Veys; D T Y Yu
Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis.
Arthritis and rheumatism 2004;51(5):691-9.
2004: Bernard Vandooren; Elli Kruithof; D T Y Yu; Markus Rihl; Jieruo Gu; Leen De Rycke; Filip Van den Bosch; Eric M Veys; Filip De Keyser; Dominique Baeten
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Arthritis and rheumatism 2004;50(9):2942-53.
2004: Dominique Baeten; Elli Kruithof; Leen De Rycke; Bernard Vandooren; Bart Wyns; Luc Boullart; I E A Hoffman; Mieke Boots; Eric M Veys; Filip De Keyser
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients.
Arthritis and rheumatism 2004;50(9):2931-41.
2004: I E A Hoffman; Isabelle Peene; Lydie Meheus; Tom W J Huizinga; L Cebecauer; D Isenberg; Katrien De Bosschere; Frank Hulstaert; Eric M Veys; Filip De Keyser
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
Annals of the rheumatic diseases 2004;63(9):1155-8.
2004: Harald Peeters; Bert Vander Cruyssen; Debby Laukens; P Coucke; D Marichal; M Van Den Berghe; Claude Cuvelier; Erik Remaut; Herman Mielants; Filip De Keyser; M D Vos
Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease.
Annals of the rheumatic diseases 2004;63(9):1131-4.
2004: Bart Wyns; S Sette; Luc Boullart; Dominique Baeten; I E A Hoffman; Filip De Keyser
Prediction of diagnosis in patients with early arthritis using a combined Kohonen mapping and instance-based evaluation criterion.
Artificial intelligence in medicine 2004;31(1):45-55.
2004: Isabelle Peene; Leen De Rycke; Dominique Baeten; I Hoffman; Eric M Veys; Filip De Keyser
History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis.
International journal of immunopathology and pharmacology 2004;17(2):107-16.
2004: Dominique Baeten; Holger Jon Møller; Joris Delanghe; Eric M Veys; Søren K Moestrup; Filip De Keyser
Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Arthritis and rheumatism 2004;50(5):1611-23.
2004: Markus Rihl; Dominique Baeten; N Seta; J Gu; Filip De Keyser; Eric M Veys; Jens G Kuipers; Henning Zeidler; D T Y Yu
Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy.
Annals of the rheumatic diseases 2004;63(5):498-507.
2004: Dominique Baeten; Filip De Keyser; Eric M Veys; Y Theate; Frédéric A Houssiau; Patrick Durez
Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules.
Annals of the rheumatic diseases 2004;63(5):489-93.
2004: Dominique Baeten; Bernard Vandooren; Leen De Rycke; Eric M Veys; Filip De Keyser
Effect of infliximab treatment on T cell cytokine responses in spondylarthropathy: comment on the article by Zou et al.
Arthritis and rheumatism 2004;50(3):1015-6; author reply 1017.
2004: Dominique Baeten; Filip De Keyser
The histopathology of spondyloarthropathy.
Current molecular medicine 2004;4(1):1-12.
2004: Dominique Baeten; Peter G A Steenbakkers; Antonius M W Rijnders; Mieke Boots; Eric M Veys; Filip De Keyser
Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker.
Arthritis and rheumatism 2004;50(2):444-51.
2004: Elli Kruithof; Dominique Baeten; Eric M Veys; Filip De Keyser; S Suykens; Lieven De Wilde; René Verdonk
Case Number 29: Ochronosis: synovial histopathological characteristics.
Annals of the rheumatic diseases 2004;63(2):130.
2004: Filip De Keyser; Dominique Baeten; Filip Van den Bosch; Elli Kruithof; Gust Verbruggen; Herman Mielants; Eric M Veys
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.
Drugs 2004;64(24):2793-811.
2003: Dominique Baeten; Elli Kruithof; Filip Van den Bosch; Nancy Van den Bossche; Annemie Herssens; Herman Mielants; Filip De Keyser; Eric M Veys
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?
Annals of the rheumatic diseases 2003;62(9):829-34.
2003: Filip De Keyser; Dominique Baeten; Filip Van den Bosch; Elli Kruithof; Herman Mielants; Eric M Veys
Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation.
Rheumatic diseases clinics of North America 2003;29(3):463-79.
2003: Peter G A Steenbakkers; Dominique Baeten; Eric Rovers; Eric M Veys; Antonius W M Rijnders; Jan Meijerink; Filip De Keyser; Mieke Boots
Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(11):5719-27.
2003: I E A Hoffman; Pieter Demetter; M Peeters; Martine De Vos; Herman Mielants; Eric M Veys; Filip De Keyser
Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
Annals of the rheumatic diseases 2003;62(5):455-9.
2003: Leen De Rycke; Elli Kruithof; Nancy Van Damme; I E A Hoffman; Nancy Van den Bossche; Filip Van den Bosch; Eric M Veys; Filip De Keyser
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
Arthritis and rheumatism 2003;48(4):1015-23.
2002: I E A Hoffman; Isabelle Peene; Eric M Veys; Filip De Keyser
Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.
Clinical chemistry 2002;48(12):2171-6.
2002: Pieter Demetter; Jacques Van Huysse; Filip De Keyser; Nancy Van Damme; Gust Verbruggen; Herman Mielants; Martine De Vos; Eric M Veys; Claude Cuvelier
Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis.
The Journal of pathology 2002;198(4):517-22.
2002: Isabelle Peene; Lydie Meheus; Eric M Veys; Filip De Keyser
Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype.
Annals of the rheumatic diseases 2002;61(12):1090-4.
2002: Filip De Keyser; Dominique Baeten; Filip Van den Bosch; Martine De Vos; Claude Cuvelier; Herman Mielants; Eric M Veys
Gut inflammation and spondyloarthropathies.
Current rheumatology reports 2002;4(6):525-32.
2002: Dominique Baeten; Filip De Keyser; Nancy Van Damme; Eric M Veys; Herman Mielants
Influence of the gut and cytokine patterns in spondyloarthropathy.
Clinical and experimental rheumatology 2002;20(6 Suppl 28):S38-42.
2002: Jieruo Gu; Markus Rihl; Elisabeth Märker-Hermann; Dominique Baeten; Jens G Kuipers; Yeong Wook Song; Walter P Maksymowych; Rubén Burgos-Vargas; Eric M Veys; Filip De Keyser; Helmuth Deister; Momiao Xiong; Feng Huang; Wen-Chan Tsai; D T Y Yu
Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles.
The Journal of rheumatology 2002;29(10):2159-64.
2002: Isabelle Peene; Lydie Meheus; S De Keyser; René-Louis Humbel; Eric M Veys; Filip De Keyser
Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
Annals of the rheumatic diseases 2002;61(10):929-33.
2002: Dominique Baeten; Filip De Keyser; Herman Mielants; Eric M Veys
Ankylosing spondylitis and bowel disease.
Best practice & research. Clinical rheumatology 2002;16(4):537-49.
2002: Dominique Baeten; Filip De Keyser; Herman Mielants; Eric M Veys
Immune linkages between inflammatory bowel disease and spondyloarthropathies.
Current opinion in rheumatology 2002;14(4):342-7.
2002: J Gu; Elisabeth Märker-Hermann; Dominique Baeten; Wen-Chan Tsai; D Gladman; M Xiong; H Deister; Jens G Kuipers; F Huang; Yeong Wook Song; Walter P Maksymowych; J Kalsi; M Bannai; N Seta; Markus Rihl; L J Crofford; Eric M Veys; Filip De Keyser; D T Y Yu
A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients.
Rheumatology (Oxford, England) 2002;41(7):759-66.
2002: Ann union; Lydie Meheus; René-Louis Humbel; Karsten Conrad; Guenter Steiner; Henri Moereels; Hans Pottel; Guy Serre; Filip De Keyser
Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay.
Arthritis and rheumatism 2002;46(5):1185-95.
2002: Filip Van den Bosch; Elli Kruithof; Dominique Baeten; Annemie Herssens; Filip De Keyser; Herman Mielants; Eric M Veys
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.
Arthritis and rheumatism 2002;46(3):755-65.
2002: Dominique Baeten; Pieter Demetter; Claude Cuvelier; Elli Kruithof; Nancy Van Damme; Martine De Vos; Eric M Veys; Filip De Keyser
Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.
The Journal of pathology 2002;196(3):343-50.
2002: Elli Kruithof; Filip Van den Bosch; Dominique Baeten; Annemie Herssens; Filip De Keyser; Herman Mielants; Eric M Veys
Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.
Annals of the rheumatic diseases 2002;61(3):207-12.
2001: Isabelle Peene; Lydie Meheus; Eric M Veys; Filip De Keyser
Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
Annals of the rheumatic diseases 2001;60(12):1131-6.
2001: Filip Van den Bosch; Dominique Baeten; Elli Kruithof; Filip De Keyser; Herman Mielants; Eric M Veys
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha.
Annals of the rheumatic diseases 2001;60 Suppl 3():iii33-6.
2001: Nancy Van Damme; Dirk Elewaut; Dominique Baeten; Pieter Demetter; Claude Cuvelier; Gust Verbruggen; Herman Mielants; Eric M Veys; Martine De Vos; Filip De Keyser
Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin.
Clinical and experimental rheumatology 2001;19(6):681-7.
2001: Dominique Baeten; Isabelle Peene; Ann union; Lydie Meheus; Mireille Sebbag; Guy Serre; Eric M Veys; Filip De Keyser
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies.
Arthritis and rheumatism 2001;44(10):2255-62.
2001: Nancy Van Damme; Filip De Keyser; Pieter Demetter; Dominique Baeten; Herman Mielants; Gust Verbruggen; Claude Cuvelier; Eric M Veys; Martine De Vos
The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
Clinical and experimental immunology 2001;125(3):383-90.
2001: Dominique Baeten; Nancy Van Damme; Filip Van den Bosch; Elli Kruithof; Martine De Vos; Herman Mielants; Eric M Veys; Filip De Keyser
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.
Annals of the rheumatic diseases 2001;60(8):750-5.
2001: Nancy Van Damme; Martine De Vos; Dominique Baeten; Pieter Demetter; Herman Mielants; Gust Verbruggen; Claude Cuvelier; Eric M Veys; Filip De Keyser
Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy.
Annals of the rheumatic diseases 2001;60(5):495-9.
2001: S Bläss; Ann union; J Raymackers; Frank Schumann; Ute Ungethüm; S Müller-Steinbach; Filip De Keyser; JM Engel; Gerd R Burmester
The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis.
Arthritis and rheumatism 2001;44(4):761-71.
2001: Filip Van den Bosch; Dominique Baeten; E Kruithof; Filip De Keyser; Eric M Veys
Characteristic marco- and microscopic aspect of the synovial membrane in crystal induced arthritis.
The Journal of rheumatology 2001;28(2):392-3.
2001: Dominique Baeten; Elli Kruithof; Filip Van den Bosch; Pieter Demetter; Nancy Van Damme; Claude Cuvelier; Martine De Vos; Herman Mielants; Eric M Veys; Filip De Keyser
Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study.
Arthritis and rheumatism 2001;44(1):186-95.
2000: kurt de vlam; Herman Mielants; Claude Cuvelier; Filip De Keyser; Eric M Veys; Martine De Vos
Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.
The Journal of rheumatology 2000;27(12):2860-5.
2000: Dominique Baeten; Pieter Demetter; Claude Cuvelier; Filip Van den Bosch; Elli Kruithof; Nancy Van Damme; Gust Verbruggen; Herman Mielants; Eric M Veys; Filip De Keyser
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity.
Annals of the rheumatic diseases 2000;59(12):945-53.
2000: Filip De Keyser; Isabelle Peene; Rik Joos; Jean-Marie Naeyaert; Ludwine MESSIAEN; Eric M Veys
Occurrence of scleroderma in monozygotic twins.
The Journal of rheumatology 2000;27(9):2267-9.
2000: Pieter Demetter; Martine De Vos; Nancy Van Damme; Dominique Baeten; Dirk Elewaut; Stefan Vermeulen; Marc Mareel; GR Bullock; Herman Mielants; Gust Verbruggen; Filip De Keyser; Eric M Veys; Claude Cuvelier
Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage.
American journal of clinical pathology 2000;114(3):364-70.
2000: Dominique Baeten; Mieke Boots; Peter G A Steenbakkers; Dirk Elewaut; Ebo S Bos; GF Verheijden; G Berheijden; André M M Miltenburg; Antonius W M Rijnders; Eric M Veys; Filip De Keyser
Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis.
Arthritis and rheumatism 2000;43(6):1233-43.
2000: Filip Van den Bosch; Elli Kruithof; Dominique Baeten; Filip De Keyser; Herman Mielants; Eric M Veys
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.
Annals of the rheumatic diseases 2000;59(6):428-33.
2000: Nancy Van Damme; Dominique Baeten; Martine De Vos; Pieter Demetter; Dirk Elewaut; Herman Mielants; Gust Verbruggen; Claude Cuvelier; Eric M Veys; Filip De Keyser
Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers.
Journal of immunological methods 2000;236(1-2):27-35.
2000: Dirk Elewaut; Filip De Keyser; Filip Van den Bosch; Gust Verbruggen; Eric M Veys
Broadening of the T cell receptor spectrum among rheumatoid arthritis synovial cell-lines in relation to disease duration.
Clinical and experimental rheumatology 2000;18(2):201-7.
2000: Pieter Demetter; Dominique Baeten; Filip De Keyser; Martine De Vos; Nancy Van Damme; Gust Verbruggen; Stefan Vermeulen; Marc Mareel; Dirk Elewaut; Herman Mielants; Eric M Veys; Claude Cuvelier
Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex.
Annals of the rheumatic diseases 2000;59(3):211-6.
2000: Filip De Keyser; Nancy Van Damme; Martine De Vos; Herman Mielants; Eric M Veys
Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2000;49(2):47-54.
2000: Isabelle Peene; W Van Ael; M Vandenbossche; T Vervaet; Eric M Veys; Filip De Keyser
Sensitivity of the HEp-2000 substrate for the detection of anti-SSA/Ro60 antibodies.
Clinical rheumatology 2000;19(4):291-5.
2000: Filip De Keyser; Jean-Marie Naeyaert; P Hindryckx; Dirk Elewaut; P Verplancke; Isabelle Peene; Marleen Praet; Eric M Veys
Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption.
Clinical and experimental rheumatology 2000;18(1):81-5.
1999: Lydie Meheus; W J van Venrooij; Allan Wiik; P J Charles; A G Tzioufas; O Meyer; G Steiner; D Gianola; S Bombardieri; Ann union; S De Keyser; Eric M Veys; Filip De Keyser
Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders.
Clinical and experimental rheumatology 1999;17(2):205-14.
1999: E Kruithof; Dirk Elewaut; Jean-Marie Naeyaert; Marleen Praet; Herman Mielants; Eric M Veys; Filip De Keyser
Polyarteritis nodosa mimicking polymyalgia rheumatica.
Clinical rheumatology 1999;18(3):257-60.
1999: Christian Vincent; Filip De Keyser; C Masson-Bessière; Mireille Sebbag; Eric M Veys; Guy Serre
Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.
Annals of the rheumatic diseases 1999;58(1):42-8.
1998: Filip De Keyser; Dirk Elewaut; Martine De Vos; kurt de vlam; Claude Cuvelier; Herman Mielants; Eric M Veys
Bowel inflammation and the spondyloarthropathies.
Rheumatic diseases clinics of North America 1998;24(4):785-813, ix-x.
1998: Dirk Elewaut; Filip De Keyser; Filip Van den Bosch; A I Lazarovits; Martine De Vos; Claude Cuvelier; Gust Verbruggen; Herman Mielants; Eric M Veys
Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis.
The Journal of rheumatology 1998;25(10):1932-7.
1998: Dirk Elewaut; Filip De Keyser; N De Wever; Dominique Baeten; Nancy Van Damme; Gust Verbruggen; Claude Cuvelier; Eric M Veys
A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers.
Annals of the rheumatic diseases 1998;57(8):480-6.
1998: Dirk Elewaut; Nancy Van Damme; Filip De Keyser; Dominique Baeten; Pascale De Paepe; Hans Van Vlierberghe; Herman Mielants; Claude Cuvelier; Gust Verbruggen; Eric M Veys; Martine De Vos
Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease.
Acta gastro-enterologica Belgica 1998;61(3):288-94.
1998: Raymond Vanholder; Filip De Keyser; J Kips; Marleen Praet; Jean-Marie Naeyaert
The pathophysiology of lupus erythematosus.
European journal of dermatology : EJD 1998;8(1):4-7.
1997: Mieke Boots; GF Verheijden; R Schöningh; C J van Staveren; Ebo S Bos; Dirk Elewaut; Filip De Keyser; Eric M Veys; I Joosten; Antonius W M Rijnders
Selection of self-reactive peptides within human aggrecan by use of a HLA-DRB1*0401 peptide binding motif.
Journal of autoimmunity 1997;10(6):569-78.
1997: Filip De Keyser; Dirk Elewaut; J P Overmeer-Graus; P Van den Broek; Antonius W M Rijnders; Eric M Veys
Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ.
The Journal of rheumatology 1997;24(9):1685-9.
1997: GF Verheijden; Antonius W M Rijnders; Ebo S Bos; Christina J J Coenen-de Roo; C J van Staveren; André M M Miltenburg; J H Meijerink; Dirk Elewaut; Filip De Keyser; Eric M Veys; Mieke Boots
Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis.
Arthritis and rheumatism 1997;40(6):1115-25.
1996: L Gyselbrecht; Filip De Keyser; K Ongenae; Jean-Marie Naeyaert; Marleen Praet; Eric M Veys
Etiological factors and underlying conditions in patients with leucocytoclastic vasculitis.
Clinical and experimental rheumatology 1996;14(6):665-8.
1996: R Schoonjans; B Van Vlem; S Weyers; Filip De Keyser; Marleen Praet; J Versieck; A Elewaut
Polyarteritis nodosa and the antiphospholipid syndrome.
Clinical rheumatology 1996;15(4):410-3.
1996: Filip De Keyser; Dirk Elewaut; N De Wever; K Bensbaho; Claude Cuvelier
The gut associated addressins: lymphocyte homing in the gut.
Baillière's clinical rheumatology 1996;10(1):25-39.
1995: Filip De Keyser; Dirk Elewaut; J Vermeersch; N De Wever; Claude Cuvelier; Eric M Veys
The role of T cells in rheumatoid arthritis.
Clinical rheumatology 1995;14 Suppl 2():5-9.
1995: kurt de vlam; Filip De Keyser; Stefan Goemaere; Marleen Praet; Eric M Veys
Churg-Strauss syndrome presenting as polymyositis.
Clinical and experimental rheumatology 1995;13(4):505-7.
1994: Herman Mielants; Eric M Veys; Filip De Keyser; G Ghyselen; Anne-Marie Malfait
Second conference on spondylarthropathies and the gut.
Clinical and experimental rheumatology 1994;12(1):111-6.
1993: Eric M Veys; Filip De Keyser
Rheumatoid nodules: differential diagnosis and immunohistological findings.
Annals of the rheumatic diseases 1993;52(9):625-6.
1993: Filip De Keyser; Gust Verbruggen; Eric M Veys; Claude Cuvelier; Anne-Marie Malfait; D Benoit; Dirk Elewaut; J Vermeersch; A Heirwegh
T cell receptor V beta usage in rheumatoid nodules: marked oligoclonality among IL-2 expanded lymphocytes.
Clinical immunology and immunopathology 1993;68(1):29-34.
1993: kurt de vlam; Filip De Keyser; Gust Verbruggen; M Vandenbossche; B Vanneuville; D D'Haese; Eric M Veys
Detection and identification of antinuclear autoantibodies in the serum of normal blood donors.
Clinical and experimental rheumatology 1993;11(4):393-7.
1993: Filip De Keyser; Herman Mielants; J Praet; Stefan Goemaere; Eric M Veys
Changes in antinuclear serology in patients with spondylarthropathy under sulphasalazine treatment.
British journal of rheumatology 1993;32(6):521.
1993: T E Feltkamp; J M Berthelot; A M Boerbooms; H G Geertzen; René M A Hoet; Filip De Keyser; Walther J van Venrooij; Gust Verbruggen; E M Veys; P Youinou
Interlaboratory variability of the antiperinuclear factor (APF) test for rheumatoid arthritis.
Clinical and experimental rheumatology 1993;11(1):57-9.
1992: E M Veys; H Mielants; G Verbruggen; Filip De Keyser
Management of early inflammatory arthritis. Intervention with immunomodulatory agents: new pharmacological developments.
Baillière's clinical rheumatology 1992;6(2):455-84.
1992: Filip De Keyser; D Benoit; Dirk Elewaut; B Leroy; Anne-Marie Malfait; Gust Verbruggen; Eric M Veys
T-cell receptor expression in patients with rheumatic diseases.
Progress in histochemistry and cytochemistry 1992;26(1-4):218-22.
1990: Stefan Goemaere; C Ackerman; K Goethals; Filip De Keyser; Catherine Van Der Straeten; Gust Verbruggen; Herman Mielants; Eric M Veys
Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition.
The Journal of rheumatology 1990;17(12):1620-2.
1990: Eric M Veys; Filip De Keyser; kurt de vlam; Gust Verbruggen
The antiperinuclear factor.
Clinical and experimental rheumatology 1990;8(5):429-31.
1990: Filip De Keyser; Gust Verbruggen; Eric M Veys; J Nimmegeers; L Schatteman; K Goethals; M Vandenbossche
"Microgel diffusion blotting" for sensitive detection of antibodies to extractable nuclear antigens.
Clinical chemistry 1990;36(2):337-9.
1990: Filip De Keyser; Gust Verbruggen; Eric M Veys; J Nimmegeers; L Schatteman; K Goethals
[Detection of antinuclear antibodies by immunoblotting from microgels. Sensitivity of the technic].
Revue du rhumatisme et des maladies ostéo-articulaires 1990;57(1):45-6.
1989: Filip De Keyser; Gust Verbruggen; E M Veys
Identification of a new antinuclear antibody by immunoblotting.
Lancet 1989;2(8668):927.
1989: Filip De Keyser; Gust Verbruggen; Eric M Veys; F Luyten; J Segers; M Rabaey
Microgel immunoblotting of thymus and nuclear extracts by unidirectional diffusion.
Analytical biochemistry 1989;176(2):350-2.